Tchorz, Jan (2024) Prometheus 2.0: Drug-induced liver regeneration arising. Cell research.

Abstract

In a recent publication in Cell, a multidisciplinary academic drug discovery team, with its spin-off HepaRegeniX, published a first-in-class small molecule MKK4 inhibitor (HRX215) with remarkable efficacy in multiple preclinical liver regeneration models and positive first-in-human data 1. Its potential to prevent liver failure and boost regeneration may provide a novel therapeutic avenue for many patients with liver disease.

Item Type:	Article
Date Deposited:	01 Oct 2024 00:45
Last Modified:	01 Oct 2024 00:45
URI:	https://oak.novartis.com/id/eprint/53709